Indican: Definition, Clinical Significance, and Management
Indican (indoxyl-β-D-glucoside) is a urinary metabolite of tryptophan produced by intestinal bacteria that serves as a marker of gut dysbiosis and small intestinal bacterial overgrowth (SIBO). Elevated urinary indican levels indicate excessive bacterial fermentation of tryptophan in the small intestine, reflecting microbial imbalance rather than a primary disease state 1, 2.
What is Indican?
Indican is formed when intestinal bacteria metabolize dietary tryptophan into indole, which is then absorbed, conjugated in the liver to indoxyl sulfate, and excreted in urine as indican 3. The metabolic pathway is:
- Dietary tryptophan → bacterial metabolism → indole → absorption → hepatic conjugation → indoxyl sulfate (uremic toxin) → urinary excretion as indican
Importantly, indoxyl sulfate is a known uremic toxin and substrate/inhibitor of organic anion transporters (OAT1, OAT3) and multidrug resistance-associated proteins (MRP4), which can interfere with drug elimination 4, 3.
Clinical Significance of Elevated Indican
Primary Indication
Elevated urinary indican concentrations indicate:
- Intestinal dysbiosis (altered gut microbiome composition)
- Small intestinal bacterial overgrowth (SIBO)
- Increased intestinal permeability or malabsorption states
Disease Associations
Research demonstrates elevated indican in:
- Parkinson's disease: Significantly higher urinary indican in both treated and de novo PD patients compared to controls, independent of constipation status 2
- Chronic kidney disease: Indoxyl sulfate accumulates as a uremic toxin in renal failure 5, 3
- Small intestinal dysmotility: Raised urinary indicans suggest bacterial overgrowth 6
Drug Interactions
Oral indican significantly increases systemic exposure to methotrexate (231-259% increase in AUC) by inhibiting renal OAT1, OAT3, and MRP4 transporters through its metabolite indoxyl sulfate 4. This is clinically relevant for patients taking:
- Methotrexate
- Other drugs eliminated via organic anion transporters
- Medications with narrow therapeutic windows
Evaluation Approach
When to Suspect Elevated Indican
Consider testing when patients present with:
- Chronic gastrointestinal symptoms (bloating, distension, altered bowel habits)
- Suspected SIBO or intestinal dysmotility
- Unexplained neurological symptoms (given PD association)
- Drug interactions with methotrexate or similar agents
- Recurrent small intestinal dysfunction
Diagnostic Testing
Urinary indican measurement is the primary diagnostic test:
- Visual detection limit: 6 mg/dL using colorimetric methods 1
- Quantitative measurement: HPLC with electrochemical detection (limits of quantitation: 5 ng/mL in serum) 5
- Newer methods: Spectrophotometry with sodium hypochlorite pentahydrate as oxidizing agent 1
Complementary Evaluation
When elevated indican is detected, evaluate for underlying causes:
- Stool studies: Rule out infectious causes of dysbiosis
- Breath testing: Hydrogen/methane breath test for SIBO confirmation
- Nutritional assessment: Vitamin B12, folate, fat-soluble vitamins (if malabsorption suspected)
- Dietary history: Assess dairy product consumption (positively associated with elevated indican) 2
- Medication review: Identify drugs metabolized via OAT/MRP pathways
Important Caveats
- Ascorbic acid interferes with chromogenic detection reactions, though ascorbate oxidase can partially suppress this 1
- Proton pump inhibitors can spuriously elevate related markers (chromogranin A), though direct interference with indican measurement is not well-documented 7, 8
- Indican levels may fluctuate; serial measurements provide better assessment than single values
Management Strategy
Step 1: Address Underlying Dysbiosis
Primary treatment targets the gut microbiome imbalance:
Dietary modification:
- Reduce fermentable carbohydrates (low FODMAP approach)
- Limit dairy products if associated with elevated levels 2
- Avoid excessive tryptophan-rich foods during acute phases
Antimicrobial therapy (if SIBO confirmed):
- Rifaximin (standard SIBO treatment)
- Rotate antibiotics if recurrent
- Consider herbal antimicrobials as alternative
Step 2: Restore Gut Barrier Function
- Probiotics: Strain-specific formulations to restore healthy microbiome
- Prebiotics: Support beneficial bacterial growth
- L-glutamine: For intestinal barrier repair (if increased permeability suspected)
Step 3: Manage Drug Interactions
For patients on methotrexate or similar drugs:
- Monitor drug levels closely if indican elevation suspected
- Adjust dosing based on therapeutic drug monitoring
- Avoid concurrent use of indican-containing herbal preparations (Isatis indigotica, Polygonum species) 4, 3
Step 4: Treat Underlying Motility Disorders
If small intestinal dysmotility identified 6:
- Prokinetic agents: Improve intestinal transit
- Address constipation: Though indican elevation in PD occurs independent of constipation 2
- Nutritional support: If malabsorption present
Step 5: Monitor Response
- Repeat urinary indican after 4-8 weeks of treatment
- Symptom tracking: Use validated GI symptom questionnaires
- Nutritional markers: Reassess if deficiencies were present
Clinical Pitfalls to Avoid
Do not assume constipation is the cause: Elevated indican in Parkinson's disease occurs independently of constipation 2
Do not overlook drug interactions: Patients taking methotrexate with elevated indican require dose adjustment and close monitoring 4
Do not rely on single measurement: Indican levels fluctuate; serial testing provides better clinical picture
Do not ignore dietary factors: Dairy consumption correlates with higher indican levels 2
Do not confuse with indocyanine green (ICG): These are completely different compounds; ICG is a diagnostic dye for liver function assessment 9